We are live on ! Find out more

1,621 hedge funds and large institutions have $127B invested in Merck in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 615 increasing their positions, 679 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 58

13% more call options, than puts

Call options by funds: $849M | Put options by funds: $749M

1% more funds holding

Funds holding: 1,6021,621 (+19)

2% more capital invested

Capital invested by funds: $125B → $127B (+$2.09B)

0.29% more ownership

Funds ownership: 77.96%78.25% (+0.29%)

9% less repeat investments, than reductions

Existing positions increased: 615 | Existing positions reduced: 679

5% less funds holding in top 10

Funds holding in top 10: 147140 (-7)

Holders
1,621
Holders Change
+19
Holders Change %
+1.19%
% of All Funds
46.57%
Holding in Top 10
140
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-4.76%
% of All Funds
4.02%
New
86
Increased
615
Reduced
679
Closed
58
Calls
$849M
Puts
$749M
Net Calls
+$101M
Net Calls Change
-$177M
Name Holding Trade Value Shares
Change
Change in
Stake
PP
251
Prospector Partners
Connecticut
$39M -$103K -1,886 -0.3%
SCM
252
Sirios Capital Management
Massachusetts
$38.5M +$38M +696,608 New
Royal London Asset Management
253
Royal London Asset Management
United Kingdom
$38.1M -$175K -3,203 -0.4%
SAM
254
Sectoral Asset Management
Quebec, Canada
$37.9M -$741K -13,577 -2%
WTNA
255
Wilmington Trust National Association
Delaware
$37.7M +$110K +2,012 +0.3%
Commonwealth Equity Services
256
Commonwealth Equity Services
Massachusetts
$37.6M +$2.09M +38,361 +6%
HNB
257
Huntington National Bank
Ohio
$37.5M -$4.11M -75,362 -10%
OPERF
258
Oregon Public Employees Retirement Fund
Oregon
$36.3M +$10.5M +191,679 +41%
WF
259
Welch & Forbes
Massachusetts
$35.6M -$79K -1,449 -0.2%
GLA
260
Great Lakes Advisors
Illinois
$35.5M -$32.9K -603 -0.1%
DC
261
Davenport & Co
Virginia
$35.2M +$482K +8,830 +1%
TGI
262
Tradewinds Global Investors
California
$34.9M -$276K -5,057 -0.8%
VLKIM
263
Van Lanschot Kempen Investment Management
Netherlands
$34.5M -$8.22M -150,755 -19%
Connor, Clark & Lunn Investment Management (CC&L)
264
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$34.2M +$19.6M +360,198 +162%
MHC
265
Meyer Handelman Company
New York
$34M +$6.82K +125 +0%
HM
266
HealthCor Management
New York
$33.8M -$32.4M -593,273 -49%
TAM
267
Todd Asset Management
Kentucky
$33.7M -$4.09M -75,054 -11%
Mitsubishi UFJ Asset Management
268
Mitsubishi UFJ Asset Management
Japan
$33.3M +$76K +1,394 +0.2%
RCM
269
Riverhead Capital Management
Delaware
$32.6M +$9M +164,997 +39%
AIA
270
Avalon Investment & Advisory
Texas
$32.2M +$372K +6,816 +1%
WG
271
Winton Group
United Kingdom
$32.1M +$31.7M +581,401 New
Asset Management One
272
Asset Management One
Japan
$31.9M -$427K -7,821 -1%
HTC
273
Haverford Trust Company
Pennsylvania
$31.8M +$777K +14,245 +3%
HCMT
274
Highland Capital Management (Tennessee)
Tennessee
$31.5M +$216K +3,961 +0.7%
MIH
275
Madison Investment Holdings
Wisconsin
$31.3M -$9.01M -165,155 -23%

MRK Hedge Fund Activity: Q2 2014 in Review

1,621 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2014, worth a combined $127B — up 1.7% from $125B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new MRK positions and 58 closed out — a net gain of 28 holders — while 615 added to existing stakes and 679 trimmed.

The largest buyer was Norges Bank, adding an estimated $1.27B. The largest seller was Fidelity Investments, cutting an estimated $623M.

  • 1,621 institutional investors held Merck (MRK) as of Q2 2014, up from 1,602 in Q1 2014.
  • Funds reported $127B of Merck stock for Q2 2014, up 1.7% quarter-over-quarter.
  • 86 funds opened new Merck positions in Q2 2014 and 58 closed out, a net change of +28 holders.
  • The largest Merck buyer in Q2 2014 was Norges Bank, an estimated $1.27B added.
  • The largest Merck seller in Q2 2014 was Fidelity Investments, an estimated $623M sold.

Based on aggregated 13F filings for Q2 2014.